High expression of ZNF93 promotes proliferation and migration of ovarian cancer cells and relates to poor prognosis

被引:0
|
作者
Cui, Xiao-Xiao [1 ,2 ]
Zhou, Chen [3 ]
Lu, Huan [2 ]
Han, Yan-Li [1 ]
Wang, Feng-Mian [2 ]
Fan, Wei-Rong [2 ]
Ren, Yuan [1 ,2 ]
Zhang, Rong [1 ,2 ]
机构
[1] Anhui Univ Sci & Technol, Huainan, Peoples R China
[2] Hlth Sci Affiliated Sixth Peoples Hosp, Dept Obstet & Gynecol, South Campus, Shanghai, Peoples R China
[3] Changzhou 2 Peoples Hosp, Dept Gynecol, Changzhou, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
Ovarian cancer; transcription factor ZNF93; small interfering siRNA; cell proliferation; cell migration; STATISTICS; APOPTOSIS;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Ovarian cancer (OC) is most common type of gynecologic cancer and is frequently lethal. It is important to determine the pathologic mechanisms underlying OC. ZNF93 is a member of the zinc finger protein family. Abnormal expression of ZNF93 has been observed in various tumor cells. However, its clinical significance and biologic function in ovarian cancer remain unclear. In the present study, we established that ZNF93 expression was highly up-regulated in OC samples and was closely correlated with clinical stage, indicating poor prognosis. We then established that ZNF93 promoted OC cell proliferation and migration. The results of our study may provide insight into the use of ZNF93 as a marker of clinical outcome and as a potential therapeutic target in OC.
引用
收藏
页码:944 / 953
页数:10
相关论文
共 50 条
  • [1] High expression of PXDN is associated with poor prognosis and promotes proliferation, invasion as well as migration in ovarian cancer
    Zheng, Ying-Ze
    Liang, Lei
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2018, 34 : 161 - 165
  • [2] Resistin Expression in Epithelial Ovarian Cancer promotes the Proliferation and Migration of Ovarian Cancer Cells to Worsen Prognosis
    Pang, Li
    Chang, Xiaohan
    JOURNAL OF CANCER, 2021, 12 (22): : 6796 - 6804
  • [3] High expression of HO-1 predicts poor prognosis of ovarian cancer patients and promotes proliferation and aggressiveness of ovarian cancer cells
    Zhao, Z.
    Xu, Y.
    Lu, J.
    Xue, J.
    Liu, P.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (04): : 491 - 499
  • [4] Correction to: High expression of HO-1 predicts poor prognosis of ovarian cancer patients and promotes proliferation and aggressiveness of ovarian cancer cells
    Z. Zhao
    Y. Xu
    J. Lu
    J. Xue
    P. Liu
    Clinical and Translational Oncology, 2018, 20 : 557 - 558
  • [5] PRSS2 overexpression relates to poor prognosis and promotes proliferation, migration and invasion in gastric cancer
    Chen, Yu
    Wang, Biling
    Zhao, Zihao
    Li, Ming
    Wang, Fei
    TISSUE & CELL, 2022, 79
  • [6] High GMFG expression correlates with poor prognosis and promotes cell migration and invasion in epithelial ovarian cancer
    Zuo, Peng
    Ma, Yuejiang
    Huang, Yongjie
    Ye, Feng
    Wang, Pei
    Wang, Xinyu
    Zhou, Caiyun
    Lu, Weiguo
    Kong, Beihua
    Xie, Xing
    GYNECOLOGIC ONCOLOGY, 2014, 132 (03) : 745 - 751
  • [7] Overexpression of Stathmin 1 Predicts Poor Prognosis and Promotes Cancer Cell Proliferation and Migration in Ovarian Cancer
    Nie, Lekai
    Zhang, Chen
    Song, Haiyun
    Zhao, Qianqian
    Cheng, Lei
    Zhang, Peihai
    Yang, Xingsheng
    DISEASE MARKERS, 2022, 2022
  • [8] High expression of GPR176 predicts poor prognosis of gastric cancer patients and promotes the proliferation, migration, and invasion of gastric cancer cells
    Zhang, Yu
    Gu, Xinliang
    Zhu, Feilong
    Li, Yang
    Huang, Yuejiao
    Ju, Shaoqing
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [9] High expression of GPR176 predicts poor prognosis of gastric cancer patients and promotes the proliferation, migration, and invasion of gastric cancer cells
    Yu Zhang
    Xinliang Gu
    Feilong Zhu
    Yang Li
    Yuejiao Huang
    Shaoqing Ju
    Scientific Reports, 13
  • [10] ZNF217 is associated with poor prognosis and enhances proliferation and metastasis in ovarian cancer
    Li, Jing
    Song, Lanlin
    Qiu, Yuwen
    Yin, Ailan
    Zhong, Mei
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (06): : 3038 - 3047